InsidersTradesSigma
Follow the 서울제약 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 서울제약 has recorded 2 public disclosures. Market capitalisation: €23.1bn. The latest transaction was filed on 1 April 2026 (Purchase). Among the most active insiders: 2018큐씨피13호사모투자. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
서울제약 is a company operating in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the research, development, and production of medicines and pharmaceutical products.